rebate-management
(2)
Girisha Fernando
Girisha Fernando is the CEO and co-founder of Lyfegen, a Basel- and Boston-based healthtech company building software that helps payers, hospitals, pharma companies and medical device makers manage value-based drug pricing, access and rebate agreements. After nearly a decade at Roche in market access, pricing and IT, he left in 2018 to build technology that ties the price of medicine to how well it actually works for patients. He splits his time between Switzerland and New York as Lyfegen pushes into the US market.
Andrew Butt
Andrew Butt is the co-founder and CEO of Enable, the San Francisco-based B2B rebate management platform that reached unicorn status in 2023 with a $1.12 billion valuation after raising $120 million in Series D funding. A UK-born entrepreneur who left school at 15 and became the youngest qualified helicopter pilot in his region at 17, Butt built his first software business from a flying school in Coventry and has spent over two decades turning overlooked operational problems in distribution and manufacturing into category-defining software companies. Enable now serves over 10,000 brands across 50+ industries and has raised more than $275 million total, with Butt positioning it as the system of record for all B2B rebate and trading agreements between manufacturers, distributors, and retailers.